India’s largest pharmaceutical industry body, the Indian Drug Manufacturers Association, presents a picture of vivid contrasts.
Section: Analysis | Thursday, January 12, 2012 10:00 IST
What started as a rare reporting subject only a few years ago has become a frequent fixture for newspapers and magazines — ethics in clinical trials in India.
Section: Analysis | Thursday, January 5, 2012 8:00 IST
While cross-border deals did not completely subside in the last one year, a long pause is becoming apparent.
Section: Analysis | Tuesday, December 20, 2011 9:15 IST
The draft National Pharmaceutical Pricing Policy floated in October by the Department of Pharmaceuticals inviting feedback from stakeholders charts out significant changes
Section: Money | Tuesday, December 13, 2011 8:33 IST
Department of Industrial Policy and Promotion’s apprehension that these companies will ignore local needs and focus only on exports is unfounded.
Section: Money | Saturday, August 28, 2010 2:23 IST
Orphan-drug maker, with a strong pipeline and sales of $4.5 billion, will be a prize catch
Section: Money | Thursday, August 5, 2010 3:14 IST
There should be all-round effort and companies should think beyond the bottomline.
Section: Money | Friday, July 23, 2010 2:19 IST
It’s important to put the safety of the patients before any opinion is shared arbitrarily.
Section: Money | Saturday, July 17, 2010 3:12 IST
Study shows greater willingness among companies to open up
Section: Money | Friday, July 2, 2010 22:59 IST
On its part, DCGI needs additional training in handling trials and more resources.
Section: Money | Friday, June 25, 2010 4:59 IST
|
Archive page 1 of 10 |
 |
Comments: 1